Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The splicing factor RBM25 controls MYC activity in acute myeloid leukemia

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Combined burden and functional impact tests for cancer driver discovery using DriverPower

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genomic footprints of activated telomere maintenance mechanisms in cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pathway and network analysis of more than 2500 whole cancer genomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. ERG Controls B Cell Development by Promoting Igh V-to-DJ Recombination

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Single mRNP Analysis Reveals that Small Cytoplasmic mRNP Granules Represent mRNA Singletons

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Functional consequences of structural variants on the 3D architecture of cancer genomes

    Research output: Book/ReportPh.D. thesisResearch

  4. Deconvolution of autoencoders to learn biological regulatory modules from single cell mRNA sequencing data

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Cancer sequencing studies have implicated regulators of pre-mRNA splicing as important disease determinants in acute myeloid leukemia (AML), but the underlying mechanisms have remained elusive. We hypothesized that "non-mutated" splicing regulators may also play a role in AML biology and therefore conducted an in vivo shRNA screen in a mouse model of CEBPA mutant AML. This has led to the identification of the splicing regulator RBM25 as a novel tumor suppressor. In multiple human leukemic cell lines, knockdown of RBM25 promotes proliferation and decreases apoptosis. Mechanistically, we show that RBM25 controls the splicing of key genes, including those encoding the apoptotic regulator BCL-X and the MYC inhibitor BIN1. This mechanism is also operative in human AML patients where low RBM25 levels are associated with high MYC activity and poor outcome. Thus, we demonstrate that RBM25 acts as a regulator of MYC activity and sensitizes cells to increased MYC levels.

Original languageEnglish
JournalNature Communications
Volume10
Issue number1
Pages (from-to)172
ISSN2041-1723
DOIs
Publication statusPublished - 11 Jan 2019

ID: 56215098